Generated by AI
Sonoma Pharmaceuticals Inc. is a healthcare company that develops and manufactures stabilized hypochlorous acid (HOCl) products used across wound care, eye care, oral and nasal care, dermatology, podiatry, animal health, and non-toxic disinfection. Its portfolio is built around topical and cleansing solutions designed for sensitive skin and tissue, supporting clinicians and patients in managing irritation, infection risk, and recovery in both medical and consumer settings. Sonoma Pharmaceuticals markets its products internationally through healthcare and specialty channels, with applications spanning acute and chronic care environments as well as veterinary uses. The company also focuses on advanced tissue care and other topical formulations, making it a niche participant in the broader pharmaceutical and medical products market. Sonoma Pharmaceuticals Inc. is headquartered in Boulder, Colorado.
Website5445 Conestoga Court
Boulder, CO, 80301
United States
The latest articles about SNOA.
Detailed price information for Sonoma Pharmaceuticals Inc (SNOA-Q) from The Globe and Mail including charting and trades.
Summary of Aug 7's posts. Generated by AI.
Summary of Aug 7's posts. Generated by AI.
Summary of Aug 7's posts. Generated by AI.
Investors talking about SNOA also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.